World’s Top 10 Pharma Companies (By 2023 Revenue)
XTalks
MAY 29, 2024
The multiple myeloma drug recently received US Food and Drug Administration (FDA) approval in earlier treatment settings. Roche also expressed hope for its two CD20xCD3 bispecific T-cell engager immunotherapies Columvi and Lunsumio that received FDA approval in 2023 and 2022, respectively. billion, an increase of 10.8
Let's personalize your content